Depression and its associated factors among people with multidrug‐resistant tuberculosis in Myanmar
Background Depression is an important potential comorbidity in persons with tuberculosis (TB), yet data in many settings are scarce. Objective To estimate the prevalence and risk factors of depression in persons with multidrug‐resistant tuberculosis (MDR‐TB) in Myanmar. Methods A cross‐sectional sur...
Gespeichert in:
Veröffentlicht in: | Tropical medicine & international health 2021-09, Vol.26 (9), p.1117-1126 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Depression is an important potential comorbidity in persons with tuberculosis (TB), yet data in many settings are scarce.
Objective
To estimate the prevalence and risk factors of depression in persons with multidrug‐resistant tuberculosis (MDR‐TB) in Myanmar.
Methods
A cross‐sectional survey among MDR‐TB participants at Aung San MDR‐TB treatment centre in Yangon during routine clinic follow‐up visits. Patients Health Questionnaire‐9 (PHQ‐9) in the local language was used to screen for depression and structured questionnaires conducted. Univariable and multivariable logistic regression models were performed to identify associations.
Results
Three‐hundred and twenty‐nine participants were enrolled between 19th December 2019 and 31st January 2020; 33% (111/329) in the intensive treatment phase. The prevalence of depressive symptoms (PHQ‐9 ≥ 10) was (34/329) 10.33%. Multivariable analysis indicated financial hardship as a result of MDR‐TB symptoms/treatment (aOR = 2.63, 95%CI: 1.12–6.67), suffering ≥1 respiratory symptoms (aOR = 6.72, 95%CI: 2.41–18.76), high education level (aOR = 4.26, 95%CI: 1.70–10.70), reported diabetes (aOR = 3.05, 95%CI: 1.16–7.99) as associated with depressive symptoms, with weak evidence of an association in females (aOR = 2.09, 95%CI: 0.94–4.65).
Conclusion
Depressive symptoms are more common in those with comorbidities/TB symptoms. Further research is required to determine the effects of interventions to support persons with depressive symptoms identified using simple, standardised validated tools like PHQ‐9. |
---|---|
ISSN: | 1360-2276 1365-3156 |
DOI: | 10.1111/tmi.13637 |